|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Gregory C. Kane , Julie A. Barta , Ronald E. Myers , Nathaniel R. Evans IIIPublisher: Springer International Publishing AG Imprint: Springer International Publishing AG Edition: 2023 ed. Weight: 0.871kg ISBN: 9783031335952ISBN 10: 3031335953 Pages: 390 Publication Date: 25 August 2023 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand We will order this item for you from a manufactured on demand supplier. Table of ContentsSECTION 1: INTRODUCTION.- Chapter 1: The Promise of Lung Cancer Screening.- Chapter 2: A Brief History of Lung Cancer Screening.- Chapter 3: Stigma and Fatalism in Lung Cancer.- Chapter 4: Screening Eligibility, Education, and Shared Decision Making.- Chapter 5: Smoking Cessation in a Lung Cancer Screening Program - Brooke Ruane, MSN, CRNP.- Chapter 6: Why Achieving Health Equity in Lung Cancer Screening is So.- SECTION 2: APPLYING A LEARNING COMMUNITY MODEL.- Chapter 7: A Health System Learning Community.- Chapter 8: Different Approaches for Offering Lung Cancer Screening.- Chapter 9: Identifying Patients Eligible for Lung Cancer Screening.- Chapter 10: Patient Outreach and Provider Support in Lung Cancer Screening.- Chapter 11: Shared Decision Making in Lung Cancer Screening.- Chapter 12: Advances in Tobacco Treatment.- SECTION 3: ORGANIZING A QUALITY PROGRAM.- Chapter 13: Organizational Workflow for Lung Cancer.- Chapter 14: Lung-RADS and Radiology Reporting Requirements.- Chapter 15: Managing Incidental Findings.- Chapter 16: Leveraging the EMR for Continuous Quality.- Chapter 17: Minimizing Harms of Screening.- Chapter 18: A Multidisciplinary Approach.- Chapter 19: Managing Lung Cancer Screening in a Major Health Care System.- Chapter 20: Cost Considerations.- SECTION 4: TAKING CARE OF THE PATIENT.- Chapter 21: Engaging Patients from Diverse Backgrounds in Lung Cancer.- Chapter 22: Modern Management of Early-Stage Lung Cancer.- Chapter 23: The Revolution of Lung Cancer Therapeutics.- SECTION 5: ENGAGING THE COMMUNITY.- Chapter 24: Lung Cancer and Social Justice – What Do I Need to Understand?.- Chapter 25: Reaching Vulnerable Populations and Areas of Need.- Chapter 26: Lung Cancer Myths and How Do I Address Them?.- Chapter 27: How to Expand Your Program’s Reach Beyond the Healthcare System and Into the Community.- SECTION 6: DETERMINING IMPACT AT THE POPULATION LEVEL.- Chapter 28: Lung Cancer Screening–Addressing Disparities.- Chapter 29: Geocoding and Assessing a Program’s Impact.- Chapter 30: Partnering with Stakeholders for Broad Impact.- SECTION 7: ON THE HORIZON: WHAT LIES AHEAD IN LUNG CANCER SCREENING.- Chapter 31: Assessing Health Systems’ Preparedness for Addressing Lung Cancer Screening at a Population Level- Chapter 32: New Partnerships in Reaching Unique Populations.- Chapter 33: Where Do We Go From Here?.- Chapter 34: Imaging an Equitable Lung Cancer ScreeningReviewsAuthor InformationGregory C. Kane, MD, MACP The Jefferson-National Jewish Health Korman Respiratory Institute Division of Pulmonary and Critical Care Medicine Department of Medicine Sidney Kimmel Medical College at Thomas Jefferson University Philadelphia, PA, USA Julie A. Barta, MD, ATSF The Jefferson-National Jewish Health Korman Respiratory Institute Division of Pulmonary and Critical Care Medicine Department of Medicine Sidney Kimmel Medical College at Thomas Jefferson University Philadelphia, PA, USA Ronald E. Myers, DSW, PhD, FSBM Division of Population Science Department of Medical Oncology Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, PA, USA Nathaniel R. Evans III, MD, FACS, FCCP The Jefferson-National Jewish Health Korman Respiratory Institute Division of Thoracic Surgery Department of Surgery Sidney Kimmel Medical College at Thomas Jefferson University Philadelphia, PA, USAu Tab Content 6Author Website:Countries AvailableAll regions |
||||